Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy

Natalizumab is an approved medication for highly active multiple sclerosis (MS). Progressive multifocal leukoencephalopathy (PML) may occur as a severe side effect of this drug. Here, we describe pathological and radiological characteristics of immune reconstitution inflammatory syndrome (IRIS), whi...

Descripción completa

Detalles Bibliográficos
Autores principales: Metz, Imke, Radue, Ernst-Wilhelm, Oterino, Agustin, Kümpfel, Tania, Wiendl, Heinz, Schippling, Sven, Kuhle, Jens, Sahraian, Mohammad Ali, Gray, Francoise, Jakl, Veronika, Häusler, Darius, Brück, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259335/
https://www.ncbi.nlm.nih.gov/pubmed/22057786
http://dx.doi.org/10.1007/s00401-011-0900-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259335/
https://www.ncbi.nlm.nih.gov/pubmed/22057786
http://dx.doi.org/10.1007/s00401-011-0900-5

Ejemplares similares